🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Massimo Radin

Centre for Biomedical Network Research on Rare Diseases

ORCID: 0000-0003-1941-2606

Also affiliated with Ospedale San Giovanni Bosco

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.487Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lara D. Veeken(2024)10.1093/rheumatology/keae583
Top 39%
0.487DataRank
Top 39%8 citations

Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Maria G. Tektonidou +23 more

Papers

Driven by 4 papers — median percentile 61. Top paper: “16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends”.

16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends

Lupus(2023)10.1177/09612033231211820
N/A
0.652DataRank · unranked
18 citations

Cecilia B Chighizola, Yuichiro Fujieda, Ian Mackie, Massimo Radin, Robert Roubey +2 more

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lara D. Veeken(2024)10.1093/rheumatology/keae583
Top 39%
0.487DataRank
Top 39%8 citations

Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Maria G. Tektonidou +23 more

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Laboratory Investigation(2023)10.1016/j.labinv.2023.100147
N/A
0.312DataRank · unranked
7 citations

Rohan Willis, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza +67 more

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Lara D. Veeken(2023)10.1093/rheumatology/kead292
N/A
0DataRank · unranked
18 citations

Yasaman Ahmadzadeh, Maria G. Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte +64 more